Vitamin D in Fatty Liver Disease
NCT04038853
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
360
Enrollment
OTHER
Sponsor class
Conditions
Non-alcoholic Fatty Liver Disease
Vitamin D Deficiency
Interventions
DRUG:
1,25-Dihydroxyvitamin D
DRUG:
Placebo
Sponsor
University Hospital Rijeka
Collaborators
[object Object]
[object Object]